Oil & Gas Equipment & Services
Compare Stocks
4 / 10Stock Comparison
NOV vs NCSM vs BKR vs HAL
Revenue, margins, valuation, and 5-year total return — side by side.
Oil & Gas Equipment & Services
Oil & Gas Equipment & Services
Oil & Gas Equipment & Services
NOV vs NCSM vs BKR vs HAL — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Oil & Gas Equipment & Services | Oil & Gas Equipment & Services | Oil & Gas Equipment & Services | Oil & Gas Equipment & Services |
| Market Cap | $6.96B | $105M | $63.00B | $32.68B |
| Revenue (TTM) | $8.69B | $180M | $27.89B | $22.17B |
| Net Income (TTM) | $91M | $19M | $3.12B | $1.54B |
| Gross Margin | 19.5% | 36.7% | 23.6% | 15.3% |
| Operating Margin | 5.3% | 5.2% | 25.3% | 11.3% |
| Forward P/E | 21.7x | 8.7x | 26.5x | 16.8x |
| Total Debt | $2.34B | $13M | $7.14B | $8.13B |
| Cash & Equiv. | $1.55B | $37M | $3.71B | $2.21B |
NOV vs NCSM vs BKR vs HAL — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| NOV Inc. (NOV) | 100 | 154.8 | +54.8% |
| NCS Multistage Hold… (NCSM) | 100 | 383.0 | +283.0% |
| Baker Hughes Company (BKR) | 100 | 384.8 | +284.8% |
| Halliburton Company (HAL) | 100 | 333.0 | +233.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NOV vs NCSM vs BKR vs HAL
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NOV is the #2 pick in this set and the best alternative if income & stability is your priority.
- Dividend streak 5 yrs, beta 1.01, yield 2.6%
- 2.6% yield, 5-year raise streak, vs BKR's 1.4%, (1 stock pays no dividend)
NCSM carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.
- Rev growth 13.6%, EPS growth 239.2%, 3Y rev CAGR 5.9%
- Lower volatility, beta 0.28, Low D/E 9.0%, current ratio 4.27x
- Beta 0.28, current ratio 4.27x
- 13.6% revenue growth vs HAL's -3.3%
BKR is the clearest fit if your priority is long-term compounding.
- 186.8% 10Y total return vs HAL's 16.2%
- 11.2% margin vs NOV's 1.0%
HAL is the clearest fit if your priority is momentum.
- +105.6% vs NCSM's +28.1%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 13.6% revenue growth vs HAL's -3.3% | |
| Value | Lower P/E (8.7x vs 16.8x) | |
| Quality / Margins | 11.2% margin vs NOV's 1.0% | |
| Stability / Safety | Beta 0.28 vs NOV's 1.01, lower leverage | |
| Dividends | 2.6% yield, 5-year raise streak, vs BKR's 1.4%, (1 stock pays no dividend) | |
| Momentum (1Y) | +105.6% vs NCSM's +28.1% | |
| Efficiency (ROA) | 11.4% ROA vs NOV's 0.8%, ROIC 7.9% vs 5.8% |
NOV vs NCSM vs BKR vs HAL — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
NOV vs NCSM vs BKR vs HAL — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
BKR leads in 2 of 6 categories
NCSM leads 2 • NOV leads 1 • HAL leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
BKR leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
BKR is the larger business by revenue, generating $27.9B annually — 155.3x NCSM's $180M. BKR is the more profitable business, keeping 11.2% of every revenue dollar as net income compared to NOV's 1.0%. On growth, BKR holds the edge at +2.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $8.7B | $180M | $27.9B | $22.2B |
| EBITDAEarnings before interest/tax | $725M | $15M | $4.5B | $3.4B |
| Net IncomeAfter-tax profit | $91M | $19M | $3.1B | $1.5B |
| Free Cash FlowCash after capex | $734M | $24M | $2.6B | $1.7B |
| Gross MarginGross profit ÷ Revenue | +19.5% | +36.7% | +23.6% | +15.3% |
| Operating MarginEBIT ÷ Revenue | +5.3% | +5.2% | +25.3% | +11.3% |
| Net MarginNet income ÷ Revenue | +1.0% | +10.8% | +11.2% | +6.9% |
| FCF MarginFCF ÷ Revenue | +8.4% | +13.2% | +9.4% | +7.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | -2.4% | -8.7% | +2.5% | -0.3% |
| EPS Growth (YoY)Latest quarter vs prior year | -73.7% | -109.3% | +132.5% | +129.2% |
Valuation Metrics
NCSM leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
At 4.6x trailing earnings, NCSM trades at a 91% valuation discount to NOV's 49.5x P/E. On an enterprise value basis, NCSM's 4.6x EV/EBITDA is more attractive than BKR's 14.0x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $7.0B | $105M | $63.0B | $32.7B |
| Enterprise ValueMkt cap + debt − cash | $7.7B | $81M | $66.4B | $38.6B |
| Trailing P/EPrice ÷ TTM EPS | 49.49x | 4.60x | 24.43x | 26.09x |
| Forward P/EPrice ÷ next-FY EPS est. | 21.73x | 8.70x | 26.48x | 16.85x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 8.43x | 4.57x | 14.00x | 11.37x |
| Price / SalesMarket cap ÷ Revenue | 0.80x | 0.57x | 2.27x | 1.47x |
| Price / BookPrice ÷ Book value/share | 1.14x | 0.76x | 3.32x | 3.13x |
| Price / FCFMarket cap ÷ FCF | 8.06x | 4.98x | 24.83x | 19.55x |
Profitability & Efficiency
NCSM leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
BKR delivers a 16.1% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $1 for NOV. NCSM carries lower financial leverage with a 0.09x debt-to-equity ratio, signaling a more conservative balance sheet compared to HAL's 0.77x. On the Piotroski fundamental quality scale (0–9), NCSM scores 6/9 vs HAL's 5/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +1.4% | +14.4% | +16.1% | +14.6% |
| ROA (TTM)Return on assets | +0.8% | +11.4% | +7.3% | +6.1% |
| ROICReturn on invested capital | +5.8% | +7.9% | +12.7% | +10.2% |
| ROCEReturn on capital employed | +6.3% | +8.4% | +13.6% | +11.6% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.37x | 0.09x | 0.38x | 0.77x |
| Net DebtTotal debt minus cash | $788M | -$24M | $3.4B | $5.9B |
| Cash & Equiv.Liquid assets | $1.6B | $37M | $3.7B | $2.2B |
| Total DebtShort + long-term debt | $2.3B | $13M | $7.1B | $8.1B |
| Interest CoverageEBIT ÷ Interest expense | 5.82x | 28.21x | 9.68x | 9.19x |
Total Returns (Dividends Reinvested)
BKR leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BKR five years ago would be worth $27,526 today (with dividends reinvested), compared to $11,957 for NOV. Over the past 12 months, HAL leads with a +105.6% total return vs NCSM's +28.1%. The 3-year compound annual growth rate (CAGR) favors BKR at 33.1% vs NOV's 8.9% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +18.2% | +0.5% | +35.7% | +32.8% |
| 1-Year ReturnPast 12 months | +67.6% | +28.1% | +77.5% | +105.6% |
| 3-Year ReturnCumulative with dividends | +29.3% | +104.9% | +136.0% | +37.4% |
| 5-Year ReturnCumulative with dividends | +19.6% | +51.4% | +175.3% | +82.6% |
| 10-Year ReturnCumulative with dividends | -31.8% | -90.0% | +186.8% | +16.2% |
| CAGR (3Y)Annualised 3-year return | +8.9% | +27.0% | +33.1% | +11.2% |
Risk & Volatility
Evenly matched — NOV and NCSM each lead in 1 of 2 comparable metrics.
Risk & Volatility
NCSM is the less volatile stock with a 0.28 beta — it tends to amplify market swings less than NOV's 1.01 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NOV currently trades 92.2% from its 52-week high vs NCSM's 45.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.01x | 0.28x | 0.83x | 0.57x |
| 52-Week HighHighest price in past year | $20.93 | $87.36 | $70.41 | $42.46 |
| 52-Week LowLowest price in past year | $11.65 | $28.64 | $35.83 | $19.22 |
| % of 52W HighCurrent price vs 52-week peak | +92.2% | +45.6% | +90.2% | +92.2% |
| RSI (14)Momentum oscillator 0–100 | 55.4 | 27.8 | 57.1 | 55.7 |
| Avg Volume (50D)Average daily shares traded | 4.8M | 38K | 9.1M | 15.0M |
Analyst Outlook
NOV leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: NOV as "Hold", BKR as "Buy", HAL as "Buy". Consensus price targets imply 13.3% upside for BKR (target: $72) vs -5.2% for HAL (target: $37). For income investors, NOV offers the higher dividend yield at 2.63% vs BKR's 1.44%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | — | Buy | Buy |
| Price TargetConsensus 12-month target | $19.38 | — | $72.00 | $37.08 |
| # AnalystsCovering analysts | 58 | — | 45 | 64 |
| Dividend YieldAnnual dividend ÷ price | +2.6% | — | +1.4% | +1.8% |
| Dividend StreakConsecutive years of raises | 5 | — | 4 | 4 |
| Dividend / ShareAnnual DPS | $0.51 | — | $0.92 | $0.69 |
| Buyback YieldShare repurchases ÷ mkt cap | +4.5% | +0.3% | +0.6% | +3.1% |
BKR leads in 2 of 6 categories (Income & Cash Flow, Total Returns). NCSM leads in 2 (Valuation Metrics, Profitability & Efficiency). 1 tied.
NOV vs NCSM vs BKR vs HAL: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is NOV or NCSM or BKR or HAL a better buy right now?
For growth investors, NCS Multistage Holdings, Inc.
(NCSM) is the stronger pick with 13. 6% revenue growth year-over-year, versus -3. 3% for Halliburton Company (HAL). NCS Multistage Holdings, Inc. (NCSM) offers the better valuation at 4. 6x trailing P/E (8. 7x forward), making it the more compelling value choice. Analysts rate Baker Hughes Company (BKR) a "Buy" — based on 45 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NOV or NCSM or BKR or HAL?
On trailing P/E, NCS Multistage Holdings, Inc.
(NCSM) is the cheapest at 4. 6x versus NOV Inc. at 49. 5x. On forward P/E, NCS Multistage Holdings, Inc. is actually cheaper at 8. 7x.
03Which is the better long-term investment — NOV or NCSM or BKR or HAL?
Over the past 5 years, Baker Hughes Company (BKR) delivered a total return of +175.
3%, compared to +19. 6% for NOV Inc. (NOV). Over 10 years, the gap is even starker: BKR returned +186. 8% versus NCSM's -90. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NOV or NCSM or BKR or HAL?
By beta (market sensitivity over 5 years), NCS Multistage Holdings, Inc.
(NCSM) is the lower-risk stock at 0. 28β versus NOV Inc. 's 1. 01β — meaning NOV is approximately 263% more volatile than NCSM relative to the S&P 500. On balance sheet safety, NCS Multistage Holdings, Inc. (NCSM) carries a lower debt/equity ratio of 9% versus 77% for Halliburton Company — giving it more financial flexibility in a downturn.
05Which is growing faster — NOV or NCSM or BKR or HAL?
By revenue growth (latest reported year), NCS Multistage Holdings, Inc.
(NCSM) is pulling ahead at 13. 6% versus -3. 3% for Halliburton Company (HAL). On earnings-per-share growth, the picture is similar: NCS Multistage Holdings, Inc. grew EPS 239. 2% year-over-year, compared to -75. 6% for NOV Inc.. Over a 3-year CAGR, BKR leads at 9. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NOV or NCSM or BKR or HAL?
NCS Multistage Holdings, Inc.
(NCSM) is the more profitable company, earning 12. 9% net margin versus 1. 7% for NOV Inc. — meaning it keeps 12. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BKR leads at 12. 8% versus 6. 4% for NCSM. At the gross margin level — before operating expenses — NCSM leads at 38. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NOV or NCSM or BKR or HAL more undervalued right now?
On forward earnings alone, NCS Multistage Holdings, Inc.
(NCSM) trades at 8. 7x forward P/E versus 26. 5x for Baker Hughes Company — 17. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BKR: 13. 3% to $72. 00.
08Which pays a better dividend — NOV or NCSM or BKR or HAL?
In this comparison, NOV (2.
6% yield), HAL (1. 8% yield), BKR (1. 4% yield) pay a dividend. NCSM does not pay a meaningful dividend and should not be held primarily for income.
09Is NOV or NCSM or BKR or HAL better for a retirement portfolio?
For long-horizon retirement investors, Halliburton Company (HAL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
57), 1. 8% yield). Both have compounded well over 10 years (HAL: +16. 2%, NOV: -31. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NOV and NCSM and BKR and HAL?
Both stocks operate in the Energy sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: NOV is a small-cap quality compounder stock; NCSM is a small-cap deep-value stock; BKR is a mid-cap quality compounder stock; HAL is a mid-cap quality compounder stock. NOV, BKR, HAL pay a dividend while NCSM does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.